Peter Andersen

Peter Andersen

Presidente en IMMUNOVIA AB .

67 años
Health Technology
Finance
Commercial Services

Perfil

Peter Høngaard Andersen was the founder of ACADIA Pharmaceuticals A, where he held the title of Vice President from 1997 to 1999.
He is also the founder of Zealand Pharma A, Glycom A, EpiTherapeutics ApS, Prexton Therapeutics SA, and InnovationsFonden.
Dr. Andersen's current job(s) include being the Chairman of the European Federation of Pharmaceutical Industries & Assns since 2014, Chairman of Immunovia AB since 2023, Chairman of Biotech Research & Innovation Centre, Chairman of Edvince AB, Director of Ossianix, Inc., Operating Partner of Forbion Capital Partners Management Holding BV since 2022, and a Member of Collegium Internationale Neuro-Psychopharmacologicum and Scandinavian Society for Psychopharmacology.
His former job(s) include being the Chairman of Lundbeck Research USA, Inc., Vice-Chairman of Scandion Oncology A in 2019, Director-Supervisory Board of to-BBB Holding BV, Director & Executive Vice President-Research of Lundbeck Pharma A from 2011 to 2014, Director of Serendex Pharmaceuticals A, Director of Imara, Inc., Director of Monsenso A, Project Manager-Metabolic Disease at Novo Nordisk A from 1984 to 1987, SVP-External Scientific Relations & Patents at H.
Lundbeck A, and Member-Supervisory Board of to-BBB technologies BV.
He was also a Venture Partner at Ysios Capital Partners SGEIC SA from 2020 to 2023.
Dr. Andersen obtained his graduate and doctorate degrees from the University of Copenhagen.
Dr. Andersen is also the founder of Zealand Pharma A, Glycom A, EpiTherapeutics ApS, Prexton Therapeutics SA, and InnovationsFonden.

Cargos activos de Peter Andersen

EmpresasCargoInicio
IMMUNOVIA AB Presidente 26/05/2023
Fundador -
Inversor de Capital Privado 20/07/2022
Biotech Research & Innovation Centre Presidente -
Scandinavian Society for Psychopharmacology Corporate Officer/Principal 04/06/2010
Director/Miembro de la Junta -
Collegium Internationale Neuro-Psychopharmacologicum Corporate Officer/Principal 04/06/2010
Director Técnico/Científico/I+D -
Presidente -
Todos los cargos activos de Peter Andersen

Antiguos cargos conocidos de Peter Andersen.

EmpresasCargoFin
░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░ -
Ver el detalle de la experiencia de Peter Andersen.

Formación de Peter Andersen.

University of Copenhagen Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Peter Andersen.

Relaciones

99

Relaciones de 1er grado

26

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas6
NOVO NORDISK A/S

Health Technology

H. LUNDBECK A/S

Health Technology

ZEALAND PHARMA A/S

Health Technology

IMMUNOVIA AB

Health Technology

MONSENSO A/S

Technology Services

SCANDION ONCOLOGY A/S

Health Technology

Empresas privadas19

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Collegium Internationale Neuro-Psychopharmacologicum

Finance

Commercial Services

Health Technology

Distribution Services

Scandinavian Society for Psychopharmacology

Health Technology

Health Technology

Health Technology

Biotech Research & Innovation Centre

Finance

Health Technology

Health Technology

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA